NCT07648225: UBT251 Injection Phase Ⅲ Study (Overweight or Obesity)
- State
- Under way
- Phase
- Phase 3
- People
- 600 planned
- Started
- 4 Sep 2026
- Primary completion
- 29 Sep 2027
- Arms
- UBT251 Injection 6.0 mg
- Results
- None posted
- 15 Jun 2026: Trial registered
- 4 Sep 2026: Trial started